Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Depreciation & Amortization
-$80.8m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Depreciation & Amortization
-$9.5B
CAGR 3-Years
2%
CAGR 5-Years
-170%
CAGR 10-Years
-55%
Pfizer Inc
NYSE:PFE
Depreciation & Amortization
-$5.2B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Supernus Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
-80.8m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Depreciation & Amortization amounts to -80.8m USD.

What is Supernus Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-50%

Over the last year, the Depreciation & Amortization growth was 1%. The average annual Depreciation & Amortization growth rates for Supernus Pharmaceuticals Inc have been -50% over the past three years .

Back to Top